Purchase Order 75N92025P00255

Award Date 7/1/25
Potential Completion Date 11/1/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, part of the Department of Health and Human Services National Institutes of Health, to Metabolon, Inc., a self-certified small disadvantaged business, for other functions metabolic analyses of art samples. The potential value of the contract is $51,060.00, with a completion date of October 31, 2017. Metabolon is a leading provider of metabolomics solutions, offering analytical methods...
This is a $160,000 firm fixed price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a small disadvantaged business. The contract is for metabolomic profiling of 800 plasma biospecimens collected from COVID-19 patients and appropriate controls, in order to generate metabolic profiles to support research initiatives related to the coronavirus pandemic. The contract was awarded...
This firm fixed-price purchase order contract was awarded by the National Institutes of Health (NIH) Clinical Center to Metabolon, Inc., a small disadvantaged business, to provide specialized metabolomics analysis services. The $22,080.00 contract has a period of performance ending on September 22, 2024. Metabolon has served as a prime contractor on numerous federal contracts, providing metabolic profiling of biological samples to support research initiatives across agencies such as the...
This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
This is a $9,800 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract supports specialized metabolomics analysis services for various research programs, including those focused on veteran health, precision medicine, and environmental health impacts. Metabolon has been awarded multiple prime contracts and...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for a project titled "Metabolic Profile of Cerebral Malaria; 100 Samples" with a ceiling value of $30,000.00 and a completion date of September 18, 2013. Metabolon, a leading provider of metabolomics solutions, has served as both a...
This is a $24,300 firm fixed-price purchase order awarded by a civilian federal agency to Metabolon, Inc., a self-certified small disadvantaged business, for metabolite profile processing services. The contract has no set-aside designation and is scheduled for completion by November 30, 2020. Metabolon is a leading provider of specialized metabolomics services and solutions to various federal agencies, offering advanced analytical capabilities in metabolite identification and quantification. The...
This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...
This is a firm-fixed price purchase order awarded by the Department of Agriculture's Agricultural Research Service to Metabolon, Inc., a small disadvantaged business, for global metabolomics services. The contract has a potential value of $249,981.48 and a completion date of August 31, 2024. Metabolon provides specialized metabolomics analysis capabilities, including the identification and quantification of thousands of metabolites, to support biomedical research and regulatory science...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to Metabolon, Inc., a self-certified small disadvantaged business. The $15,000.00 contract is for the collection and analysis of 48 24-hour urine samples from a low-calorie-low-fat (LCLF) diet intervention study. Metabolon, a leading provider of metabolomics services, will leverage its proprietary analytical platforms to identify and quantify metabolites...

This is a $19,672.56 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Metabolon, Inc., a small disadvantaged business. The contract is for metabolomic analysis of brain samples from mice with WASF3 gene modification to investigate the role of WASF3 in cognitive function related to myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Metabolon is a leading provider of specialized metabolomics services, and this award leverages their expertise and proprietary analytical platforms to support NHLBI's research on the underlying mechanisms of ME/CFS. The contract has an ultimate completion date of November 1, 2025 and was awarded on July 1, 2025. Metabolon has previously served as both a prime contractor and subcontractor on numerous federal contracts and grants with agencies such as the VA, NIH, FDA, DoD, EPA, and USDA to provide metabolomics analysis in support of various healthcare, biomedical, and environmental research initiatives.

Generated 7/8/25, 2:22 PM